Population-Based Study of Pertussis Incidence and Risk Factors among Persons >50 Years of Age, Australia
- PMID: 38146987
- PMCID: PMC10756356
- DOI: 10.3201/eid3001.230261
Population-Based Study of Pertussis Incidence and Risk Factors among Persons >50 Years of Age, Australia
Abstract
Despite vaccination programs, pertussis has been poorly controlled, especially among older adults in Australia. This longitudinal, retrospective, observational study aimed to estimate the incidence and risk factors of pertussis among persons ≥50 years of age in Australia in the primary care setting, including those with underlying chronic obstructive pulmonary disease (COPD) or asthma. We used the IQVIA general practitioner electronic medical record database to identify patients ≥50 years of age with a clinical diagnosis of pertussis during 2015-2019. Pertussis incidence rates ranged from 57.6 to 91.4 per 100,000 persons and were higher among women and highest in those 50-64 years of age. Patients with COPD or asthma had higher incidence rates and an increased risk for pertussis compared with the overall population ≥50 years of age. Our findings suggest that persons ≥50 years of age in Australia with COPD or asthma have a higher incidence of and risk for pertussis diagnosis.
Keywords: Australia; COPD; Pertussis; asthma; bacteria; elderly; incidence; respiratory infections; risk factors; vaccination; vaccine-preventable diseases; whooping cough.
Figures





Similar articles
-
Incidence and Healthcare Burden of Pertussis among Older Adults with and without Pre-Existing Chronic Obstructive Pulmonary Disease or Asthma in South Korea.COPD. 2023 Dec;20(1):126-134. doi: 10.1080/15412555.2023.2169120. COPD. 2023. PMID: 37093711
-
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.Hum Vaccin Immunother. 2023 Dec 31;19(1):2159731. doi: 10.1080/21645515.2022.2159731. Epub 2023 Feb 6. Hum Vaccin Immunother. 2023. PMID: 36746754 Free PMC article.
-
Tetanus, diphtheria, and acellular pertussis vaccine coverage in adults with chronic respiratory conditions.Ann Allergy Asthma Immunol. 2023 Sep;131(3):333-337.e4. doi: 10.1016/j.anai.2023.04.008. Epub 2023 Apr 19. Ann Allergy Asthma Immunol. 2023. PMID: 37080456
-
Pertussis in high-risk groups: an overview of the past quarter-century.Hum Vaccin Immunother. 2020 Nov 1;16(11):2609-2617. doi: 10.1080/21645515.2020.1738168. Epub 2020 Apr 16. Hum Vaccin Immunother. 2020. PMID: 32298213 Free PMC article. Review.
-
The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review.Expert Rev Vaccines. 2019 May;18(5):439-455. doi: 10.1080/14760584.2019.1588727. Epub 2019 Mar 25. Expert Rev Vaccines. 2019. PMID: 30887849
Cited by
-
Real-Life Insights into Pertussis Diagnosis: High Yield of PCR Testing and Clinical Outcomes-An Emerging Old Enemy or Just a Sign of PCR Times?J Pers Med. 2024 Nov 22;14(12):1116. doi: 10.3390/jpm14121116. J Pers Med. 2024. PMID: 39728029 Free PMC article.
-
Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions.Expert Rev Vaccines. 2024 Jan-Dec;23(1):705-714. doi: 10.1080/14760584.2024.2383745. Epub 2024 Jul 24. Expert Rev Vaccines. 2024. PMID: 39037200 Free PMC article. Review.
-
Pertussis Vaccination for Adults: An Updated Guide for Clinicians.Vaccines (Basel). 2025 Jan 11;13(1):60. doi: 10.3390/vaccines13010060. Vaccines (Basel). 2025. PMID: 39852839 Free PMC article. Review.
References
-
- Australian Government Department of Health. Pertussis (whooping cough) 2021. [cited 2023 Jul 13]. https://immunisationhandbook.health.gov.au/vaccine-preventable-diseases/...
-
- Australian Technical Advisory Group on Immunisation (ATAGI). Pertussis. In: The Australian immunisation handbook, 10th edition. Canberra: Australian Government Department of Health; 2015. p. 312–26.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical